Craneware, the Scottish supplier of financial software to the US healthcare market, has warned that profit and revenue growth for the year will be below market expectations.
In a trading update the board said FY26 revenue will come in between $205-$208 million with adjusted EBITDA of $65-$67m, both broadly in line with FY25.
This change results from product conversion into revenue and the deferral of a small number of significant enterprise contracts, which are now expected to contribute during FY27.
Customer retention, customer demand and cash generation have remained strong throughout the year, said the Edinburgh-based company. However, the pace of turning opportunities into drug purchases slowed significantly.
The board of the AIM-quoted company believes that these factors reflect a short-term timing impact to the FY26 results.
It said that, looking ahead, customer demand is increasingly extending beyond software and analytics towards technology-enabled operational transformation that helps healthcare providers realise the opportunities identified by the group’s platform.
Craneware has been developing these capabilities over the last three years and they now represent a meaningful and growing component of the group’s offering. This reinforces, rather than diminishes, the long-term strategic importance of Craneware’s platform within the evolving US healthcare ecosystem.
The board will provide a further update with the announcement of the Group’s full year results in September 2026.
Keith Neilson, CEO, said: “Naturally we are disappointed not to have delivered the growth that we expected in FY26. While the short-term complexity in the pharmacy market has impacted the year, the long-term opportunity remains intact.
“This reinforces our strategy of expanding beyond software and analytics into technology-enabled operational transformation that helps customers realise the opportunities identified by the group’s platform, and this is a continuing area of focus for our innovation efforts.
“We believe this strengthens both our customer relationships and our long-term growth opportunity, as healthcare providers increasingly seek trusted partners capable of combining data, workflow automation and operational expertise to deliver measurable financial outcomes.
“Our role is evolving from helping customers identify opportunity to helping them realise it.
“We continue to benefit from high levels of customer retention and cash generation, providing us with a strong financial foundation to execute on our strategy.”
Business Bulletin: Sign up for our breakfast email of the day’s breaking news
#Craneware #takes #revenue #hit #contract #delays #Daily #Business